What is the study about?

This is an exciting new clinical trial using an investigational drug for the treatment of Major Depressive Disorder (MDD) in people who have had an inadequate response to other antidepressants.  Worldwide, about 15% of the adult population is at lifetime risk of developing MDD. This has a significant effect on people’s ability to lead fulfilling lives. Developing an effective drug for previously treatment resistant depression is thus a research priority.

Who can take part?

If you have a diagnosis of depression and are aged 18 to 65, or know someone who is and would benefit from this research please get in touch.

What is involved?

Participants will be randomly assigned to receive either an active drug or placebo. They will be required to visit the clinic 7 times (over 12 weeks) to complete physical and health checks. All expenses are covered.

How do I get involved?

If you are interested in the study or would like some more information please contact us on 01932 722247 or research@sabp.nhs.uk.